Market Tracker

04/24 7:06am ET

Novavax Inc (NASDAQ:NVAX)

0.8291
Delayed Data
As of Apr 21
 +0.0048 / +0.58%
Today’s Change
0.73
Today|||52-Week Range
8.49
-34.20%
Year-to-Date
No recent news for Novavax Inc.

Today’s Trading

Previous close0.82
Today’s open0.84
Day’s range0.82 - 0.84
Volume3,067,099
Average volume (3 months)6,464,913
Market cap$225.5M
Dividend yield--
Data as of 04/21/2017

Growth & Valuation

Earnings growth (last year)-71.67%
Earnings growth (this year)+39.76%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-57.65%
P/E ratioNM
Price/Sales22.22
Price/Book--

Competitors

 Today’s
change
Today’s
% change
AKTXAkari Therapeutics P...+4.13+25.23%
TOCATocagen Inc-0.33-2.43%
ENZYEnzymotec Ltd+0.15+1.68%
CGENCompugen Ltd-0.08-1.86%
Data as of 04/21/2017

Financials

Next reporting dateMay 10, 2017
EPS forecast (this quarter)-$0.17
Annual revenue (last year)$15.4M
Annual profit (last year)-$280.0M
Net profit margin-1,823.53%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stanley C. Erck
Chief Financial Officer, Treasurer &
Senior VP
Barclay A. Phillips
Corporate headquarters
Gaithersburg, Maryland

Forecasts